Skip to main content
. 2022 Apr 15;3(2):e154. doi: 10.1097/AS9.0000000000000154

TABLE 3.

Demographic, Clinical, and Perioperative Data of High-risk Population

Easy Flow (n = 26) Salem Sump (n = 47) P
Age (y, mean± SD) 65.3 ± 10.5 67.5 ± 13.3 0.457*
Gender, n (%) 0.216§
 Male 12 (46.1) 30 (63.8)
 Female 14 (53.9) 17 (36.2)
BMI (kg/m2, mean± SD) 24.4 ± 3.6 24.3 ± 3.8 0.886*
ASA, n (%) 0.269§
 1 2 (7.7) 1 (2.2)
 2 14 (53.8) 23 (48.9)
 3 9 (34.6) 23 (48.9)
 4 1 (3.9) 0 (0.0)
Diabetes, n (%) 0.548
 Yes 0 (0.0) 3 (6.4)
 No 26 (100) 44 (93.6)
COPD, n (%) 0.124
 Yes 2 (7.7) 0 (0.0)
 No 24 (92.3) 47 (100.0)
Smoking, n (%) 0.147§
 Yes 9 (34.6) 8 (17.0)
 No 17 (65.4) 39 (83.0)
Neoadjuvant CT-RT, n (%) 0.229
 Yes 3 (11.5) 12 (25.5)
 No 23 (88.5) 35 (74.5)
Preoperative biliary drainage, n (%) 0.075§
 Yes 13 (50.0) 13 (27.6)
 No 13 (50.0) 34 (72.4)
Vascular resection n (%) 0.785§
 Yes 8 (30.8) 12 (25.5)
 No 18 (69.2) 35 (74.5)
Blood losses (ml, median, IQR) 400.0 (287.5–525.0) 250.0 (200.0–450.0) 0.040
Duration of procedure (min, median, IQR) 240.0 (207.5–300.0) 215.0 (184.0–255.0) 0.045
POPF, n (%) <0.001 §
 Yes 18 (69.2) 6 (12.7)
 No 8 (30.8) 41 (87.3)
Length of stay (days, median, IQR) 21.0 (17.3–26.3) 18.0 (14.0–25.0) 0.091
Severe complications, n (%) 0.096§
 Yes 10 (38.4) 9 (19.1)
 No 16 (61.6) 38 (80.2)
Mortality, n (%) 0.340
 Yes 3 (13.0) 2 (4.2)
 No 23 (87.0) 45 (95.8)

Bold indicates statistically significant values (P < 0.05).

*Student t test.

†Fischer’s exact test.

‡Mann-Whitney U test.

§Chi square test.

ASA indicates American Society of Anesthesiologists physical status classification; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CT, chemotherapy; IQR, interquartile range; POPF, postoperative pancreatic fistula; RT, radiotherapy.